科尔奇辛急性减少肝脏分泌的血液中的炎症和代谢蛋白质
Magdalena Sovakova1, Iain R Phair1, Erika Gutierrez-Lara1
1Cellular and Systems Medicine, School of Medicine, University of Dundee, Dundee, DD1 9SY, UK.
European journal of pharmacology
|March 9, 2026
概括
胆固醇影响肝脏通路,影响补充剂,胆固醇和凝血. 这项研究揭示了菌素如何改变血清蛋白质,影响心血管健康和免疫反应.
科学领域:
- 心血管科学 心血管科学
- 蛋白质组学是指蛋白质组学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 科尔奇辛已被批准用于动脉样硬化心血管疾病 (ASCVD),但其机制尚未完全理解.
- 需要一种全系统的方法来研究菌素的急性作用.
研究的目的:
- 在小鼠中识别由菌素诱导的血清和血蛋白质组的急性变化.
- 为了阐明受素影响的依赖肝脏的途径.
主要方法:
- 使用了量化数据独立获取 (DIA) 质谱法.
- 给小鼠吃的是标准的食或高胆固醇饮食.
- 使用定量PCR进行交叉验证.
主要成果:
- 胆固醇抑制了依赖肝脏的途径:补充,胆固醇代谢和凝血.
- 血清中阿波利波蛋白水平降低,影响LDL/VLDL含量.
- 胆固醇的肝脏作用,部分通过ERK1/2和JNK,调解这些蛋白质变化.
结论:
- 急性粉素的使用会调节肝脏衍生成分的血清和血蛋白质组.
- 系统性代谢和免疫变化是由菌素诱导的.
- 这些发现提供了关于黄素在ASCVD治疗效果的见解.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
629
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
629
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
307
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
307
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
688
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
688
Drugs for Treatment of Ulcerative Colitis in IBD
582
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
582
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Inflammatory Bowel Disease I: Ulcerative Colitis
1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K


